FILTER

FILTERED INTERVIEW RESULTS

United States
Pharma & Life Sciences

James Sapirstein

PRESIDENT & CEO, AZURRX BIOPHARMA
AzurRx Biopharma has benefitted from the availability of financing to expand its pipeline.
United States
Pharma & Life Sciences

William H. Lewis

CHAIR & CEO, INSMED
2020 has been a transformative year for Insmed that is now undertaking three exciting programs for rare and serious diseases.
United States
Pharma & Life Sciences

Christiana Bardon

PORTFOLIO MANAGER, BURRAGE CAPITAL, MANAGING DIRECTOR, ONCOLOGY IMPACT FUND, MPM CAPITAL
Burrage Capital speaks to GBR about the current wave of enthusiasm investors are showing towards biotech.
United States
Pharma & Life Sciences

Jay A. Roberts

PRESIDENT & CEO, CANCER GENETICS, INC.
Cancer Genetics has merged with StemoniX and is addressing the challenges of drug discovery using innovative, science-based technologies and a highly-developed focus on the regulatory community.
United States
Pharma & Life Sciences

Kendalle O’Connell

PRESIDENT AND COO, MASSBIO
MassBio explains how it intends to ensure that Massachusetts remains a global leader for life sciences.
United States
Pharma & Life Sciences

Daphne Zohar & Bharatt Chowrira

FOUNDER AND CEO & PRESIDENT AND CHIEF OF BUSINESS AND STRATEGY, PURETECH HEALTH
PureTech Health is expanding swiftly with 24 product candidates that it has invented or initiated, 13 of which are in clinical testing, and two have received FDA clearance.
United States
Pharma & Life Sciences

Peter DeYoung

CEO, PIRAMAL GLOBAL PHARMA
Piramal Global Pharma is responding to growing demand with rapid expansion in the CDMO space.
United States
Pharma & Life Sciences

Gil Roth

PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
PBOA explains why the CDMO sector enjoys a higher profile.
United States
Pharma & Life Sciences

Debbie Hart

FOUNDING PRESIDENT & CEO, BIONJ
BioNJ relates how New Jersey’s thriving life sciences sector is benefitting from a tremendous boost.
United States
Pharma & Life Sciences

Chris Garabedian

CHAIRMAN & CEO, XONTOGENY
Xontogeny explains how it can help young companies to cross the valley of death.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Peru Mining 2024 Pre-Release II

As the second half of 2024 approaches, Peru stands at a crossroads. According to the latest figures, the Democratic Republic of Congo has surpassed Peru as the second-largest copper producer. Cabinet changes under Boluarte's administration and ongoing corruption cases have taken a toll on investor confidence, and illegal mining remains a pressing issue. However, not everything is lost for the Andean country, and the mining sector presents growth opportunities.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL